Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Intestinal2466 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A02600 | 34315516 | Chin Med | Herbal therapy for ameliorating nonalcoholic fatty liver disease via rebuilding the intestinal microecology. | 2021 | Details |
| A02630 | 34303710 | Biochem Pharmacol | Pregnane X receptor exacerbates nonalcoholic fatty liver disease accompanied by obesity- and inflammation-prone gut microbiome signature. | 2021 | Details |
| A02643 | 34298930 | Int J Mol Sci | Upregulation of Anti-Oxidative Stress Response Improves Metabolic Changes in L-Selectin-Deficient Mice but Does Not Prevent NAFLD Progression or Fecal Microbiota Shifts. | 2021 | Details |
| A02644 | 34298870 | Int J Mol Sci | Liver Injury and the Macrophage Issue: Molecular and Mechanistic Facts and Their Clinical Relevance. | 2021 | Details |
| A02656 | 34295987 | Clin Exp Hepatol | Correlation of endoscopic findings with Doppler ultrasound in portal hypertension in children. | 2021 | Details |
| A02695 | 34280073 | Tissue Barriers | Role of microbiota and related metabolites in gastrointestinal tract barrier function in NAFLD. | 2021 | Details |
| A02697 | 34279051 | Obes Rev | Dietary fiber-derived short-chain fatty acids: A potential therapeutic target to alleviate obesity-related nonalcoholic fatty liver disease. | 2021 | Details |
| A02709 | 34276380 | Front Pharmacol | Chlorogenic Acid Improves NAFLD by Regulating gut Microbiota and GLP-1. | 2021 | Details |
| A02727 | 34271043 | Int J Biol Macromol | Structural characterization of two novel polysaccharides from Gastrodia elata and their effects on Akkermansia muciniphila. | 2021 | Details |
| A02728 | 34270928 | Cell Metab | FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption. | 2021 | Details |
| A02733 | 34267042 | Curr Opin Infect Dis | The impact of alteration in gut microbiome in the pathogenesis of nonalcoholic fatty liver disease. | 2021 | Details |
| A02766 | 34251802 | J Agric Food Chem | Oleanolic Acid Targets the Gut-Liver Axis to Alleviate Metabolic Disorders and Hepatic Steatosis. | 2021 | Details |
| A02784 | 34242656 | Am J Pathol | Methionine- and Choline-Deficient Diet-Induced Nonalcoholic Steatohepatitis Is Associated with Increased Intestinal Inflammation. | 2021 | Details |
| A02792 | 34239138 | Nat Med | Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial. | 2021 | Details |
| A02796 | 34236487 | Semin Immunopathol | Role of bile acids in inflammatory liver diseases. | 2021 | Details |
| A02798 | 34235516 | Food Funct | The interaction between gut microbiota and flavonoid extract from Smilax glabra Roxb. and its potent alleviation of fatty liver. | 2021 | Details |
| A02832 | 34225483 | mBio | Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice. | 2021 | Details |
| A02835 | 34225424 | Zhonghua Gan Zang Bing Za Zhi | [Role of gut-liver-immune axis in the pathogenesis of nonalcoholic steatohepatitis]. | 2021 | Details |
| A02840 | 34222711 | Curr Opin Endocr Metab Res | Pediatric nonalcoholic fatty liver disease and the microbiome: Mechanisms contributing to pathogenesis and progression. | 2021 | Details |
| A02868 | 34211711 | SAGE Open Med | Frequency and risk factors of non-alcoholic fatty liver disease in Helicobacter pylori-infected dyspeptic patients: A cross-sectional study. | 2021 | Details |
| A02870 | 34211180 | Nat Metab | Intestinal MYC modulates obesity-related metabolic dysfunction. | 2021 | Details |
| A02871 | 34211157 | Nat Rev Gastroenterol Hepatol | New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology. | 2021 | Details |
| A02878 | 34208774 | Int J Mol Sci | Atorvastatin Modulates Bile Acid Homeostasis in Mice with Diet-Induced Nonalcoholic Steatohepatitis. | 2021 | Details |
| A02881 | 34206629 | Nutrients | Perinatal High-Salt Diet Induces Gut Microbiota Dysbiosis, Bile Acid Homeostasis Disbalance, and NAFLD in Weanling Mice Offspring. | 2021 | Details |
| A02892 | 34204274 | Int J Mol Sci | Nonalcoholic Fatty Liver Disease (NAFLD) as Model of Gut-Liver Axis Interaction: From Pathophysiology to Potential Target of Treatment for Personalized Therapy. | 2021 | Details |
| A02898 | 34203178 | Int J Mol Sci | Intestinal Permeability Is a Mechanical Rheostat in the Pathogenesis of Liver Cirrhosis. | 2021 | Details |
| A02906 | 34201382 | Nutrients | Beyond the Paradigm of Weight Loss in Non-Alcoholic Fatty Liver Disease: From Pathophysiology to Novel Dietary Approaches. | 2021 | Details |
| A02920 | 34199035 | Int J Mol Sci | The Role of Fatty Acids in Non-Alcoholic Fatty Liver Disease Progression: An Update. | 2021 | Details |
| A02927 | 34195217 | Front Nutr | Grape Polyphenols Attenuate Diet-Induced Obesity and Hepatic Steatosis in Mice in Association With Reduced Butyrate and Increased Markers of Intestinal Carbohydrate Oxidation. | 2021 | Details |
| A02953 | 34186207 | Free Radic Biol Med | Gut inflammation exacerbates high-fat diet induced steatosis by suppressing VLDL-TG secretion through HNF4α pathway. | 2021 | Details |
| A02961 | 34183709 | Sci Rep | The mechanism of increased intestinal palmitic acid absorption and its impact on hepatic stellate cell activation in nonalcoholic steatohepatitis. | 2021 | Details |
| A02973 | 34177920 | Front Immunol | Prebiotic Inulin and Sodium Butyrate Attenuate Obesity-Induced Intestinal Barrier Dysfunction by Induction of Antimicrobial Peptides. | 2021 | Details |
| A02977 | 34176456 | Curr Pharm Des | Gut Microbiota as an Emerging Therapeutic Avenue for the Treatment of Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02984 | 34174048 | J Gastrointestin Liver Dis | Non-alcoholic fatty liver disease and cardiovascular disease: a close relationship. | 2021 | Details |
| A03001 | 34168615 | Front Endocrinol (Lausanne) | Unhealthy Lifestyle and Gut Dysbiosis: A Better Understanding of the Effects of Poor Diet and Nicotine on the Intestinal Microbiome. | 2021 | Details |
| A03003 | 34168408 | World J Gastroenterol | COVID-19 and pediatric fatty liver disease: Is there interplay? | 2021 | Details |
| A03012 | 34164507 | Ann Transl Med | Butyrate ameliorates alcoholic fatty liver disease via reducing endotoxemia and inhibiting liver gasdermin D-mediated pyroptosis. | 2021 | Details |
| A03024 | 34159911 | Wiad Lek | THE EFFECT OF DOXORUBICIN-INDUCED OXIDATIVE STRESS ON CITRULLINE CONCENTRATION IN THE SMALL INTESTINAL MUCOSA AND PLASMA BLOOD IN RATS WITH NON-ALCOHOLIC STEATOHEPATITIS. | 2021 | Details |
| A03034 | 34156021 | Wiad Lek | NON-ALCOHOLIC FATTY LIVER DISEASE IN THE CONTEXT OF ALTERED GUT MICROBIOTA. | 2021 | Details |
| A03056 | 34152053 | J Sleep Res | Metabolic dysfunction in OSA: Is there something new under the sun? | 2021 | Details |
| A03057 | 34151600 | Physiol Genomics | Alterations in bile acid metabolizing gut microbiota and specific bile acid genes as a precision medicine to subclassify NAFLD. | 2021 | Details |
| A03069 | 34142875 | Crit Rev Food Sci Nutr | Research progress on intervention effect and mechanism of protocatechuic acid on nonalcoholic fatty liver disease. | 2021 | Details |
| A03076 | 34139927 | Pharm Biol | Tocopheryl quinone improves non-alcoholic steatohepatitis (NASH) associated dysmetabolism of glucose and lipids by upregulating the expression of glucagon-like peptide 1 (GLP-1) via restoring the balance of intestinal flora in rats. | 2021 | Details |
| A03103 | 34130208 | Nutr Res | A rise in Proteobacteria is an indicator of gut-liver axis-mediated nonalcoholic fatty liver disease in high-fructose-fed adult mice. | 2021 | Details |
| A03114 | 34125646 | Gut Microbes | Desulfovibrio vulgaris, a potent acetic acid-producing bacterium, attenuates nonalcoholic fatty liver disease in mice. | 2021 | Details |
| A03134 | 34118321 | Gastroenterol Hepatol | Fecal microbiota transplant, its usefulness beyond Clostridioides difficile in gastrointestinal diseases. | 2021 | Details |
| A03161 | 34107545 | Semin Liver Dis | Gut-Liver Axis in Nonalcoholic Fatty Liver Disease: the Impact of the Metagenome, End Products, and the Epithelial and Vascular Barriers. | 2021 | Details |
| A03181 | 34097961 | Int J Biol Macromol | A homogeneous polysaccharide from Lycium barbarum: Structural characterizations, anti-obesity effects and impacts on gut microbiota. | 2021 | Details |
| A03214 | 34087406 | Food Chem Toxicol | Quercetin and non-alcoholic fatty liver disease: A review based on experimental data and bioinformatic analysis. | 2021 | Details |
| A03220 | 34082879 | J Biomed Nanotechnol | Study on the Inhibitory Effects of Naringenin-Loaded Nanostructured Lipid Carriers Against Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A03265 | 34065444 | Nutrients | Gut Microbiota Induced by Pterostilbene and Resveratrol in High-Fat-High-Fructose Fed Rats: Putative Role in Steatohepatitis Onset. | 2021 | Details |
| A03268 | 34065241 | Biology (Basel) | Treating the Metabolic Syndrome by Fecal Transplantation-Current Status. | 2021 | Details |
| A03278 | 34063865 | Metabolites | The Role of AKR1B10 in Physiology and Pathophysiology. | 2021 | Details |
| A03282 | 34062416 | Biomed Pharmacother | The HIF-2α/PPARα pathway is essential for liraglutide-alleviated, lipid-induced hepatic steatosis. | 2021 | Details |
| A03285 | 34060951 | Endocr Res | AST-120 Treatment Alters the Gut Microbiota Composition and Suppresses Hepatic Triglyceride Levels in Obese Mice. | 2021 | Details |
| A03294 | 34057877 | Expert Rev Clin Immunol | The pathogenic oral-gut-liver axis: new understandings and clinical implications. | 2021 | Details |
| A03295 | 34057682 | Cell Mol Neurobiol | The Role of Epigenomic Regulatory Pathways in the Gut-Brain Axis and Visceral Hyperalgesia. | 2021 | Details |
| A03296 | 34056769 | Phytother Res | Molecular updates on berberine in liver diseases: Bench to bedside. | 2021 | Details |
| A03308 | 34050561 | J Gastroenterol Hepatol | Development of a machine learning model to predict bleed in esophageal varices in compensated advanced chronic liver disease: A proof of concept. | 2021 | Details |
| A03317 | 34047448 | Mol Nutr Food Res | Soyasaponin A2 Alleviates Steatohepatitis Possibly through Regulating Bile Acids and Gut Microbiota in the Methionine and Choline-Deficient (MCD) Diet-induced Nonalcoholic Steatohepatitis (NASH) Mice. | 2021 | Details |
| A03325 | 34043691 | PLoS One | Evaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: A Taiwanese retrospective cohort study. | 2021 | Details |
| A03340 | 34035098 | BMJ Open | PUTRA-Adol study: protocol for an observational follow-up study to assess the tracking of dietary patterns linked to cardiometabolic risk factors and its prospective relationship with non-alcoholic fatty liver disease, carotid intima-medial thickness and mental well-being during adolescence in Malaysia. | 2021 | Details |
| A03378 | 34025071 | World J Gastroenterol | Partially hydrolyzed guar gum attenuates non-alcoholic fatty liver disease in mice through the gut-liver axis. | 2021 | Details |
| A03431 | 34002333 | Diabetes Ther | Effects of Liraglutide on Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. | 2021 | Details |
| A03450 | 33995404 | Front Immunol | Trans Fatty Acid Intake Induces Intestinal Inflammation and Impaired Glucose Tolerance. | 2021 | Details |
| A03453 | 33994854 | Int J Biol Sci | Berberine alleviates lipid metabolism disorders via inhibition of mitochondrial complex I in gut and liver. | 2021 | Details |
| A03462 | 33992651 | Int J Biol Macromol | Lycium barbarum polysaccharide combined with aerobic exercise ameliorated nonalcoholic fatty liver disease through restoring gut microbiota, intestinal barrier and inhibiting hepatic inflammation. | 2021 | Details |
| A03463 | 33992352 | Food Res Int | Caffeic acid prevents non-alcoholic fatty liver disease induced by a high-fat diet through gut microbiota modulation in mice. | 2021 | Details |
| A03466 | 33991837 | Bioorg Chem | Anti-inflammatory effect of luteolin is related to the changes in the gut microbiota and contributes to preventing the progression from simple steatosis to nonalcoholic steatohepatitis. | 2021 | Details |
| A03476 | 33989817 | Cell Mol Gastroenterol Hepatol | Sodium Butyrate Supplementation Inhibits Hepatic Steatosis by Stimulating Liver Kinase B1 and Insulin-Induced Gene. | 2021 | Details |
| A03506 | 33978391 | Minerva Gastroenterol (Torino) | Probiotics and gut health. | 2021 | Details |
| A03508 | 33977946 | Food Funct | DHA-enriched phosphatidylserine ameliorates non-alcoholic fatty liver disease and intestinal dysbacteriosis in mice induced by a high-fat diet. | 2021 | Details |
| A03511 | 33975804 | Trends Endocrinol Metab | Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease. | 2021 | Details |
| A03526 | 33969054 | World J Clin Cases | Polycystic ovary syndrome: Pathways and mechanisms for possible increased susceptibility to COVID-19. | 2021 | Details |
| A03528 | 33967606 | Int J Med Sci | H. pylori is related to NAFLD but only in female: A Cross-sectional Study. | 2021 | Details |
| A03537 | 33965368 | Arch Biochem Biophys | Vitamin D ameliorates high-fat-diet-induced hepatic injury via inhibiting pyroptosis and alters gut microbiota in rats. | 2021 | Details |
| A03540 | 33962692 | Microbiome | Iron status influences non-alcoholic fatty liver disease in obesity through the gut microbiome. | 2021 | Details |
| A03556 | 33957682 | Semin Liver Dis | New Developments in Microbiome in Alcohol-Associated and Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A03570 | 33951119 | J Gastrointestin Liver Dis | The Interrelationship Among Non-Alcoholic Fatty Liver Disease, Colonic Diverticulosis and Metabolic Syndrome. | 2021 | Details |
| A03572 | 33948987 | FASEB J | Porphyran-derived oligosaccharides alleviate NAFLD and related cecal microbiota dysbiosis in mice. | 2021 | Details |
| A03579 | 33946843 | Microorganisms | Gut Microbiota and NAFLD: Pathogenetic Mechanisms, Microbiota Signatures, and Therapeutic Interventions. | 2021 | Details |
| A03601 | 33936094 | Front Immunol | The Role of the Gut-Liver Axis in Metabolic Dysfunction-Associated Fatty Liver Disease. | 2021 | Details |
| A03618 | 33928675 | Hepatology | Inhibition of Secretin/Secretin Receptor Axis Ameliorates NAFLD Phenotypes. | 2021 | Details |
| A03620 | 33928009 | Clin Nephrol Case Stud | Severe type-B lactic acidosis in a patient with bilateral renal Burkitt's lymphoma. | 2021 | Details |
| A03628 | 33925122 | Curr Issues Mol Biol | Effect of Bombyx mori on the Liver Protection of Non-Alcoholic Fatty Liver Disease Based on In Vitro and In Vivo Models. | 2021 | Details |
| A03630 | 33924725 | Nutrients | The Combination of Berberine, Tocotrienols and Coffee Extracts Improves Metabolic Profile and Liver Steatosis by the Modulation of Gut Microbiota and Hepatic miR-122 and miR-34a Expression in Mice. | 2021 | Details |
| A03662 | 33917049 | Int J Mol Sci | Sex and Race-Related DNA Methylation Changes in Hepatocellular Carcinoma. | 2021 | Details |
| A03665 | 33915261 | J Nutr Biochem | Consumption of soybean or olive oil at recommended concentrations increased the intestinal microbiota diversity and insulin sensitivity and prevented fatty liver compared to the effects of coconut oil. | 2021 | Details |
| A03701 | 33898959 | JHEP Rep | Potent suppression of hydrophobic bile acids by aldafermin, an FGF19 analogue, across metabolic and cholestatic liver diseases. | 2021 | Details |
| A03703 | 33897617 | Front Endocrinol (Lausanne) | Mining Gut Microbiota From Bariatric Surgery for MAFLD. | 2021 | Details |
| A03705 | 33897464 | Front Physiol | Free Fatty Acid Receptors as Mediators and Therapeutic Targets in Liver Disease. | 2021 | Details |
| A03707 | 33896117 | Liver Int | Combined analysis of gut microbiota, diet and PNPLA3 polymorphism in biopsy-proven non-alcoholic fatty liver disease. | 2021 | Details |
| A03711 | 33895191 | Pharmacol Ther | The pathophysiological function of non-gastrointestinal farnesoid X receptor. | 2021 | Details |
| A03718 | 33894097 | Liver Int | A nonbile acid farnesoid X receptor agonist tropifexor potently inhibits cholestatic liver injury and fibrosis by modulating the gut-liver axis. | 2021 | Details |
| A03731 | 33887125 | United European Gastroenterol J | Gut fermentation syndrome: A systematic review of case reports. | 2021 | Details |
| A03732 | 33885128 | Food Funct | Modulation of the fecal microbiome and metabolome by resistant dextrin ameliorates hepatic steatosis and mitochondrial abnormalities in mice. | 2021 | Details |
| A03757 | 33873073 | J Pharm Biomed Anal | Investigation of the therapeutic effect of Yinchen Wuling Powder on CCl4-induced hepatic fibrosis in rats by 1H NMR and MS-based metabolomics analysis. | 2021 | Details |
| A03766 | 33871224 | Minerva Gastroenterol (Torino) | Gut microbiota and non-alcoholic fatty liver disease. | 2021 | Details |
| A03771 | 33869077 | Front Cell Infect Microbiol | The Role of Gut Microbiota in Duodenal-Jejunal Bypass Surgery-Induced Improvement of Hepatic Steatosis in HFD-Fed Rats. | 2021 | Details |
| A03776 | 33867442 | Eur J Gastroenterol Hepatol | Small intestinal bacterial overgrowth and orocecal transit time in patients of nonalcoholic fatty liver disease. | 2021 | Details |